This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: